Invited Speakers
Home > Program > Invited Speakers

Plenary Lecture

  • Plenary Lecture 1 Mechanisms of resistance to endocrine therapy in ER+ breast cancer
    Carlos L. Arteaga UT Southwestern Medical Center USA CV
  • Plenary Lecture 2 Mechanism of Action and Inflammatory Axis for Air Pollution Induced Non-Small Cell Lung Cancer
    Charles Swanton Francis Crick Institute UK CV
  • Plenary Lecture 3 SCRUM-MONSTAR & CIRCULATE
    -Japan platform to accelerate precision oncology innovations; achievement and perspective
    Takayuki Yoshino The National Cancer Center Hospital East (NCCE) in Chiba Japan CV
  • Plenary Lecture 4 The past & future journey of cancer immunotherapy
    Roy S. Herbst Yale School of Medicine USA CV

SCIENTIFIC SYMPOSIUM

Scientific Symposium 1 T cells need our help to fight cancer, beyond PD-1/PD-L1 inhibitors
  • Omid Hamid The Angeles Clinic and Research Institute USA CV
  • Eui-Cheol Shin KAIST Graduate School
    of Medical Science and Engineering     Republic of Korea CV
  • Chungyong Han National Cancer Center Republic of Korea CV
  • Prasad S. Adusumilli Memorial Sloan Kettering Cancer Center USA CV
Scientific Symposium 2 The next step in the treatment of GU cancers
  • Mike Groaning Amgen USA CV
  • Jonathan Rosenberg Memorial Sloan Kettering Cancer Center USA CV
  • Woo Kyun Bae Chonnam National University Medical School and Hwasun Hosptial Republic of Korea CV
  • Jae Lyun Lee Asan Medical Center Republic of Korea CV
Scientific Symposium 3 Treatment for NSCLC: The earlier, the better?
  • Mark Awad Dana-Farber Cancer Institute USA CV
  • Benjamin Besse Gustave Roussy France CV
  • Hee Kyung Ahn Gachon University Gil Medical Center Republic of Korea CV
  • Dae Ho Lee Asan Medical Center Republic of Korea CV
Scientific Symposium 4 Advance of perioperative chemotherapy in resectable or potentially resectable GI cancer
  • Sun Young Rha Yonsei Cancer Center Republic of Korea CV
  • Jin-Young Jang Seoul National University Hospital Republic of Korea CV
  • Thierry Conroy University of Lorraine France CV
  • Myriam Chalabi Netherlands Cancer Institute Netherlands CV
Scientific Symposium 5 Advances in genomics technology and its clinical adaptation
  • Maximilian Diehn Stanford University USA CV
  • Young Seok Ju KAIST Graduate School of Medical Science and Engineering / Genome Insight Inc. Republic of Korea CV
  • Hae-Ock Lee The Catholic University of Korea Republic of Korea CV
  • Abhishek Jha Elucidata USA CV
Scientific Symposium 6 Artificial intelligence-empowered precision medicine in oncology: Cancer diagnosis, biomarker development, and drug discovery
  • Adam Yala UC Berkeley and UCSF USA CV
  • Jeanne Shen Stanford University USA CV
  • Kwon Joong Na Seoul National University Hospital Republic of Korea CV
  • Chaok Seok Seoul National University Republic of Korea CV
Scientific Symposium 7 The blueprint for next-generation therapeutics
  • Xin Gao Massachusetts General Hospital USA CV
  • Ecaterina Elena Dumbrava The University of Texas, MD Anderson Cancer Center USA CV
  • Chul-Woong Chung LegoChem Biosciences, Inc. Republic of Korea CV
  • Elisabetta Leo Bioscience, Oncology R&D, AstraZeneca UK CV
Scientific Symposium 8 Recent strategies in treatment advances for metastatic GI cancers
  • Kohei Shitara National Cancer Center Hospital East Japan CV
  • Wungki Park Memorial Sloan Kettering Cancer Center USA CV
  • Arndt Vogel Hannover Medical School Germany CV
  • Zev A. Wainberg UCLA USA CV
Scientific Symposium 9 Recent advances in breast cancer treatment
  • Soo Chin Lee Cancer Science Institute of Singapore, National University of Singapore (NUS) Singapore CV
  • Barbara Pistilli Gustave Roussy France CV
  • Andrei Goga University of California San Francisco USA CV
  • Kyong Hwa Park Korea University Anam Hospital Republic of Korea CV

JOINT SYMPOSIUM

ASCO/KSMO Joint Symposium 1 Targeting rare genomic aberrations in precision oncology
  • Lori J. Wirth Massachusetts General Hospital USA CV
  • Miso Kim Seoul National University Hospital Republic of Korea CV
  • Amin Nassar Yale University USA CV
  • Hee Kyung Kim Chungbuk National University Hospital Republic of Korea CV
Joint Symposium 2 (KSP/KSMO) Location matters: How spatial data is driving precision medicine
  • Alexander Swarbrick Garvan Institute of Medical Research, UNSW Sydney Australia CV
  • Jungmin Choi Korea University College of Medicine Republic of Korea CV
  • Minsun Jung Yonsei University College of Medicine Republic of Korea CV
  • Joe Yeong Singapore General Hospital Singapore CV
Joint Symposium 3 (KCSG/KSMO) The near future of precision medicine - One more step
  • Woong-Yang Park Samsung Medical Center Republic of Korea CV
  • Yeon Hee Park Samsung Medical Center Republic of Korea CV
  • Richard L. Schilsky The University of Chicago USA CV
  • Jee Hyun Kim Seoul National University Bundang Hospital Republic of Korea CV
Joint Symposium 4 (KOSRO/KSMO) Advances in non-operative, organ-preserving strategy
  • William A. Hall Medical College of Wisconsin USA CV
  • Se Hoon Park Samsung Medical Center Republic of Korea CV
  • Tomoya Yokota Shizuoka Cancer Center Japan CV
  • Kyung Hwan Kim Yonsei Cancer Center Republic of Korea CV
Joint Symposium 5 (ESMO/KSMO) Multiomics approach for precision medicine
  • Benedikt Westphalen University of Munich Germany CV
  • Rodrigo Dienstmann Vall d'Hebron Institute of Oncology (VHIO) Spain CV
  • Se-Hoon Lee Samsung Medical Center Republic of Korea CV
  • Jangho Cho The Catholic University of Korea Incheon St. Mary's Hospital Republic of Korea CV
Joint Symposium 6 (ASCO/KSMO) Recent updates in multimodality cancer treatment
  • Sandra W. Ryeom Columbia University Irving Medical Center USA CV
  • Everett E. Vokes University of Chicago Medicine and Biological Sciences USA CV
  • Jung Yong Hong Samsung Medical Center Republic of Korea CV
  • Min Hwan Kim Yonsei University College of Medicine Republic of Korea CV
Joint Symposium 7 (JSMO/KSMO) Emerging Immuno-Oncology Strategy in Solid Tumors
  • Yasutoshi Kuboki National Cancer Center Japan Japan CV
  • Shigehisa Kitano Cancer Institute Hospital of JFCR Japan CV
  • Moon Ki Choi National Cancer Center Republic of Korea CV
  • In-Ho Kim The Catholic University of Korea Seoul St. Mary's Hospital Republic of Korea CV
Joint Symposium 8 (KSR/KSMO) Integrating interventional techniques in the immunotherapy landscape: Novel insights from radiology and oncology
  • Hyo-Cheol Kim Seoul National University Hospital Republic of Korea CV
  • Hyun Pyo Hong Kangbuk Samsung Hospital Republic of Korea CV
  • Hong Jae Chon Cha University Bundang Medical Center Republic of Korea CV
Joint Symposium 9 (ESMO/KSMO) Immunooncology: Holistic perspectives for oncologists
  • Jo Van Ginderachter Vrije Universiteit Brussel Belgium CV
  • Lisa Derosa Institut Gustave Roussy France CV
  • Hye Ryun Kim Severance Hospital Republic of Korea CV
  • Ji-Yeon Kim Samsung Medical Center Republic of Korea CV
Joint Symposium 10 (KSSO/KSMO) Hereditary cancer - Diagnosis & proper management
  • Kyung-Hun Lee Seoul National University Hospital Republic of Korea CV
  • Ji Soo Park Yonsei Cancer Center Republic of Korea CV
  • Jai Min Ryu Samsung Medical Center Republic of Korea CV
  • Ji Won Park Seoul National University Hospital Republic of Korea CV

FACO SESSION

FACO Session 1 Recent updates in colorectal cancer treatment
  • Sun Young Kim Asan Medical Center Republic of Korea CV
  • Ying Yuan The Second Affiliated Hospital Zhejiang University School of Medicine China CV
  • Eiji Oki Kyushu University Japan CV
FACO Session 2 Proposals for new FACO clinical trials
  • Sehhoon Park Samsung Medical Center Republic of Korea CV
  • Ning Li Cancer Hospital Chinese Academy of Medical Sciences China CV
  • Keiichi Fujiwara Saitama Medical University International Medical Center Japan CV

EDUCATION SESSION

Education Session 1 (KOREAN) Basics of precision medicine for medical oncologists: What else should we know beyond NGS?
  • In Hae Park Korea University Guro Hospital Republic of Korea CV
  • Han Sang Kim Severance Hospital Republic of Korea CV
  • Chan-Young Ock Lunit Inc. Republic of Korea CV
  • Sun-Young Kong National Cancer Center Republic of Korea CV
Education Session 2 (KOREAN) Practical points in conducting clinical trials
  • Hyojin Kim Seoul National University Bundang Hospital Republic of Korea CV
  • In Hee Lee Kyungpook National University Chillgok Hospital Republic of Korea CV
  • Yun-Gyoo Lee Kangbuk Samsung Hospital Republic of Korea CV
  • Jae-Joon Kim Pusan National University Yangsan Hospital Republic of Korea CV
Education Session 3 (KOREAN) ABCs of novel therapeutics for solid cancers: What should we know?
  • Yang-Gun Suh National Cancer Center Republic of Korea CV
  • Kwang Suk Lim Kangwon National University Republic of Korea CV
  • Kimun Kwon Inno.N Republic of Korea CV

MULTI-DISCIPLINARY CASE DISCUSSION

Multi-Disciplinary Case Discussion (KOREAN) Multidisciplinary approach for patients with oligo-metastasis in the era of precision medicine
  • Min Hwan Kim Yonsei Cancer Center Republic of Korea CV
  • Hyeong-Gon Moon Seoul National University Hospital Republic of Korea CV
  • Kyubo Kim Ewha Womans University Mokdong Hospital Republic of Korea CV
  • In Hae Park Korea University Guro Hospital Republic of Korea CV
  • Jin Won Kim Seoul National University Bundang Hospital Republic of Korea CV
  • In-seob Lee Asan Medical Center Republic of Korea CV
  • Jeong Il Yu Samsung Medical Center Republic of Korea CV
  • Sun Young Rha Yonsei Cancer Center Republic of Korea CV

Luncheon Symposium

  • Luncheon Symposium 1 Latest Advances in Small Cell Lung Cancer Treatment
    Hyun Ae JUNG Samsung Medical Center Republic of Korea CV
  • Luncheon Symposium 2 Evolution and future of ribociclib in HR+HER2- mBC treatment
    Ji-Yeon KIM Samsung Medical Center Republic of Korea CV
  • Luncheon Symposium 3 Change HER Destiny: Implementing ENHERTU in Practice and Practical Considerations
    Jae Ho JEONG Asan Medical Center Republic of Korea CV
  • Luncheon Symposium 4 More TOMORROWs for her: Pembrolizumab, The cutting edge in Women's Cancer
    Soo jung LEE Kyungpook National University Chillgok Hospital Republic of Korea CV
  • Luncheon Symposium 5 Long-term outcome of abemaciclib in HR+, HER2 - high-risk early breast cancer
    In Hae PARK Korea University Guro Hospital Republic of Korea CV
  • Luncheon Symposium 6 Lazertinib: Redefining the treatment journey in EGFR mutant NSCLC - From 1st line
    Byoung Chul CHO Severance Hospital Republic of Korea CV

Satellite Symposium

  • Satellite Symposium 1 Pembrolizumab and Chemotherapy Combinations, the Global SOC in the 1st line Treatment for NSCLC, HNSCC, and Esophageal Cancer
    Ji-Hyun PARK Konkuk University Medical Center Republic of Korea CV
  • Satellite Symposium 2 New Era of 1L Treatment for HER2 negative GC / GEJC / EAC with Nivolumab
    Hye Seung LEE Seoul National University Hospital Republic of Korea CV
  • Satellite Symposium 2 New Era of 1L Treatment for HER2 negative GC / GEJC / EAC with Nivolumab
    Min Kyu JUNG Yonsei Cancer Center Republic of Korea CV
  • Satellite Symposium 3 Optimizing Efficacy, Safety and QoL Balance of CDK 4/6 Inhibitors in Treating HR+/HER2- Breast Cancer Patients
    Jieun LEE The Catholic University of Korea Seoul St. Mary's Hospital Republic of Korea CV
  • Satellite Symposium 4 The first ADC in la/mUC treatment, Enfortumab Vedotin landed in Korea
    In-Ho KIM The Catholic University of Korea Seoul St. Mary's Hospital Republic of Korea CV
  • Satellite Symposium 5 Recent Update in Study for pattern, efficacy and safety of use of Bevacizumab or Cetuximab in patients with metastatic colorecatal cancer when added to FOLFIRI treatment
    Seung Hoon BEOM Yonsei Cancer Center Republic of Korea CV
  • Satellite Symposium 6 A new perspectives & future paradigm shift of treatment for advanced gastric cancer
    Jin-Soo KIM Seoul National University Boramae Medical Center Republic of Korea CV
  • Satellite Symposium 6 A new perspectives & future paradigm shift of treatment for advanced gastric cancer
    Hyung-Don KIM Asan Medical Center Republic of Korea CV
  • Satellite Symposium 7 State-of-the-Art Neo/Adjuvant treatment in pancreatic Cancer: Guidance for Oncologist
    Chung Ryul OH Chung-Ang University Hospital Republic of Korea CV
  • Satellite Symposium 8 Navigating the role of Lenvatinib in Hepatocellular Carcinoma : An Up-to-Date Data Review and Emerging Treatment Strategies
    Jaekyung CHEON Asan Medical Center Republic of Korea CV
  • Satellite Symposium 9 Where are we from a perspective of patient centricity in terms of Flexcare?
    Elaine LIM National Cancer Center Singapore Singapore CV
  • Satellite Symposium 10 Treatment for metastatic colorectal cancer : Focused on FTD/TPI
    Kyung Hye BANG Chung-Ang University Gwangmyeong Hospital Republic of Korea CV
  • Satellite Symposium 11 Addressing unmet needs in the treatment of patients with metastatic triple-negative breast cancer
    Adam BRUFSKY Comprehensive Breast Cancer Center, UPMC Hillman Cancer Center, University of Pittsburgh USA CV
  • Satellite Symposium 12 Recent advances in Targeting EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer: mobocertinib
    Sun Min LIM Yonsei University College of Medicine Republic of Korea CV
  • Satellite Symposium 13 Optimizing Treatment for Patients with Metastatic Pancreatic Cancer
    Jeesun YOON Seoul National University Hospital Republic of Korea CV
  • Satellite Symposium 14 Digital solutions for precision medicine - Highly curated genomic analysis platform
    Cindy Shen HUANG Roche Diagnostics, APAC Region Taiwan CV
  • Satellite Symposium 15 Real World data and treatment experience with Avelumab in patients with locally advanced or metastatic urothelial carcinoma; Focusing on first real world results from Korean Expanded Access Program
    Inkeun PARK Asan Medical Center Republic of Korea CV

Collaborative Symposium

Collaborative Symposium Antibody-Drug Conjugates: Rise of New Therapeutic Strategies
  • Solange PETERS Lausanne University Hospital Switzerland CV
  • Hyun Cheol CHUNG Yonsei Cancer Center Republic of Korea CV

Master Class

Collaborative Symposium When common cancer meets NGS
  • Sun Min LIM Yonsei University College of Medicine Republic of Korea CV
  • Tae Min KIM Seoul National University Hospital Republic of Korea CV
  • Beung Chul AHN National Cancer Center Republic of Korea CV
  • Min Hee HONG Yonsei Cancer Center Republic of Korea CV